Services at the UM Medical Center
See a complete list of Specialty Services and Departments at UMMC.Vitamins
Description
An in-depth report on the dietary importance of vitamins and other nutrients.
Alternative Names
Carotenoids; Flavonoids; Phytochemicals
References
Wilt T, Ishani A, MacDonald R, Stark G, Mulrow C, Lau J. Beta-sitosterols for Benign Prostatic Hyperplasia (Cochrane Review). Chichester, UD: John Wiley & Sons, Ltd.; Issue 3, 2006.
Huang HY, Caballero B, Chang S, et al.The efficacy and safety of multivitamin and mineral supplement use to prevent cancer and chronic disease in adults: A systematic review for a National Institutes of Health State-of-the-Science Conference. Ann Intern Med . 2006 Jul 31; [Epub ahead of print]
Bairati I, Meyer F, Gelinas M, et al. Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients. J Clin Oncol . 2005 Aug 20;23(24):5455-7.
Borek C. Dietary Antioxidants and Human Cancer. Integrative Cancer Therapies. 2004 3: 333-341.
Prasad KN. Multiple Dietary Antioxidants Enhance the Efficacy of Standard and Experimental Cancer Therapies and Decrease Their Toxicity. Integrative Cancer Therapies. 2004 3: 310-322.
Li, H, Kantoff PW, Giovannucci P et al. Manganese Superoxide Dismutase Polymorphism, Prediagnostic Antioxidant Status, and Risk of Clinical Significant Prostate Cancer. Cancer Research. 2005;65: 2498-2504.
Villa P. L-folic acid supplementation in healthy postmenopausal women: effect on homocysteine and glycolipid metabolism. J Clin Endocrinol Metab. 2005; 90(8): 4622-9.
Duffield-Lillico AJ, Reid ME, Turnull BW, et al. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: A summary report of the Nutritional Prevention of Cancer Trial. Cancer Epid Biomarkers. Prev 11:630-639, 2002.
Heinonen OP, Albanes D, Huttunen JK, et al. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J. Natl Cancer Inst. 90:440-6, 1998.
Corrada MM, Kawas CH, Hallfrisch J, Muller D, Brookmeyer R.Reduced risk of Alzheimer’s disease with high folate intake: The Baltimore Longitudinal Study of Aging. Alzheimer's & Dementia: The Journal of the Alzheimer's Association. 2005;1:11-18.
Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LA, Guallar E. Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med . 2005;142:37-46.
Levy AP, Gerstein HC, Miller-Lotan R, Ratner R, McQueen M, Lonn E, Pogue J. The Effect of Vitamin E Supplementation on Cardiovascular Risk in Diabetic Individuals With Different Haptoglobin Phenotypes. Diabetes Care. 2004 27: 2767.
Lonn E, Bosch J, Yusef S, et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA . 2005;293:1338-1347.
Etminan M, Gill SS, Samii A. Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta-analysis Lancet Neurol.2005; 4(6): 362-5.
The HOPE and HOPE-TOO Trial Investigators. Effects of Long-term vitamin E supplementation on cardiovascular events and cancer: A randomized controlled trial. JAMA. 293:1138-1347, 2005.
Clark L.C., Combs GF Jr, Turnbull B.W., et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA. 276:1957-1963, 1996.
Duffield-Lillico AJ, Reid ME, Turnull BW, et al. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: A summary report of the Nutritional Prevention of Cancer Trial. Cancer Epid Biomarkers. Prev 11:630-639, 2002.
Heinonen OP, Albanes D, Huttunen JK, et al. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J. Natl Cancer Inst. 90:440-6, 1998.
Weinstein SJ, Wright ME, Pietinen P, et al. Serum alpha-tocopherol and gamma-tocopherol in relation to prostate cancer risk in a prospective study. J Natl Cancer Inst. 97:396-399, 2005.
The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 342: 145-153, 2000.
The Heart Outcomes Prevention Evaluation Study Investigators. Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med. 342: 154-160, 2000.
John F. Aloia, MD; Sonia Arunabh Talwar, MD; Simcha Pollack, PhD; James Yeh, PhD. A Randomized Controlled Trial of Vitamin D 3 Supplementation in African American Women. Arch Intern Med . 2005; 165: 1618 – 1623.
Bertone-Johnson ER Hankinson SE, Bendich A, Johnson SR, Willett WC, Manson JE. and vitamin D intake and risk of incident premenstrual syndrome. Arch Intern Med . 2005; 165:1246-1252.
Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LA, Guallar E. Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med . 2005;142:37-46.
Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:154-60.
McNeil JJ, Robman L, Tikellis G, Sinclair MI, McCarty CA, Taylor HR. Vitamin E supplementation and cataract: randomized controlled trial. Ophthalmology. 2004;111:75-84.
Lonn E, Bosch J, Yusef S, et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA . 2005;293:1338-1347.
Bagchi D, Sen CK, Bagchi M, Atalay M. Anti-angiogenic, antioxidant, and anti-carcinogenic properties of a novel anthocyanin-rich berry extract formula. Biochemistry (Mosc). 2004;69(1):75-80, 1 p preceding 75.
Roy S, Khanna S, Alessio HM, Vider J, Bagchi D, Bagchi M, Sen CK. Anti-angiogenic property of edible berries. Free Radic Res. 2002 Sep;36(9):1023-31.
Blodi BA, Nutritional supplements in the prevention of age-related macular degeneration. Insight . 2004 Jan-Mar;29(1):15-6; quiz 17-8.
Head KA, Natural therapies for ocular disorders, part two: cataracts and glaucoma. Altern Med Rev . 2001 Apr;6(2):141-66.
- Review Date: 8/23/2006
- Reviewed By: Harvey Simon, MD, Editor-in-Chief, Associate Professor of Medicine, Harvard Medical School; Physician, Massachusetts General Hospital
|
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process . A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch). |
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997-2007 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
Email this Page
Print this Page